ICC Melanoma 2019

Translate the description into English (United States) using Google Translate?Translate the description back to Italian (Italy)

COME GESTIRE LA TOSSICITÀ E VALUTARE LA RISPOSTA ALL’IMMUNOTERAPIA NEI PAZIENTI CON MELANOMA

La terapia immunologica del melanoma sta attraversando una fase di grande evoluzione, grazie agli importanti risultati ottenuti in molti studi clinici, a partire dal 2010, a seguito dell’introduzione degli anticorpi diretti contro i checkpoint immunologici come CTLA-4 e, in particolare, PD-1. Lo scopo di questo progetto è di approfondire i principali scenari di difficile gestione del paziente affetto da melanoma in terapia con anticorpi ant-PD-1, attraverso esempi di situazioni cliniche interattive.
HOW TO MANAGE TOXICITY AND ASSESS THE ANSWER TO IMMUNOTHERAPY IN MELANOMA PATIENTS

The immunological therapy of melanoma is going through a phase of great evolution, thanks to the important results obtained in many clinical studies, starting from 2010, following the introduction of antibodies against immunological checkpoints such as CTLA-4 and, in particular, PD -1. The purpose of this project is to investigate the main scenarios of difficult management of melanoma patients treated with ant-PD-1 antibodies, through examples of interactive clinical situations.
Read more
Collapse
Loading...

What's New

Versione iniziale
Read more
Collapse

Additional Information

Updated
June 14, 2019
Size
Varies with device
Installs
10+
Current Version
1.0
Requires Android
4.1 and up
Content Rating
Everyone
Interactive Elements
Users Interact
Permissions
Offered By
Forum Service s.r.l.
Developer
Via Martin Piaggio 17/6 16122 Genova GE
©2020 GoogleSite Terms of ServicePrivacyDevelopersArtistsAbout Google|Location: United StatesLanguage: English (United States)
By purchasing this item, you are transacting with Google Payments and agreeing to the Google Payments Terms of Service and Privacy Notice.